Blood transfusion · people with acute UGIH
1 finding from 1 review
UGIH‐related mortality · people with acute UGIH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
SAEs · people with acute UGIH
1 finding from 1 review
All‐cause mortality · people with acute UGIH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
NSAEs · people with acute UGIH
1 finding from 1 review
Rebleeding · people with acute UGIH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood transfusion · people with acute UGIH
1 finding from 1 review
UGIH‐related mortality · people with acute UGIH
1 finding from 1 review
SAEs · people with acute UGIH
1 finding from 1 review
Visualisation of gastric mucosa · people with acute UGIH
It is very uncertain whether erythromycin changes visualisation of gastric mucosa compared with nasogastric tube lavage (very low certainty).
1 finding from 1 review
Exacerbation of IBD · IBD patients
Etoricoxib showed no clear difference in exacerbation of IBD compared with placebo (low certainty).
1 finding from 1 review
Incidence of gastric cancer ‐ modified ITT analysis Histological examination · healthy asymptomatic H. pylori‐infected individuals
H. pylori eradication therapy probably leads to lower incidence of gastric cancer ‐ modified ITT analysisHistological… compared with control (moderate certainty).
1 finding from 1 review
Death from gastric cancer ‐ modified ITT analysis · healthy asymptomatic H. pylori‐infected individuals
H. pylori eradication therapy probably leads to lower death from gastric cancer ‐ modified ITT analysis compared with control (moderate certainty).
1 finding from 1 review
Intervention not reported
Colonic transit rate (geometric centre of radioactive substance). Unit indicates position along with intestinal tract. Scale from: 1 (small intestine) to 5 (rectosigmoid area). · children with chronic constipation
1 finding from 1 review
Intervention not reported
Self‐perceived QoL (change from baseline) measured using Peds QL 4.0 Generic Core Scales, scoring 0‐100 points, higher score indicates better quality of life) · children with chronic constipation
1 finding from 1 review
Intervention not reported
Parent‐perceived QoL (change from baseline) measured using PedsQL 4.0 Generic Core Scales, scoring 0‐100 points, higher score indicates better quality of life) · children with chronic constipation
1 finding from 1 review
Serious adverse events ‐ mild disease to quiescent (up to 52 weeks) · IBD patients
It is very uncertain whether oral ferric maltol changes serious adverse events ‐ mild disease to quiescent (up to 52 weeks) compared with oral placebo (very low certainty).
1 finding from 1 review
Number of responders · IBD patients
It is very uncertain whether oral ferric maltol changes number of responders ‐ mild disease to quiescent (up to 52 weeks) compared with oral placebo (very low certainty).
1 finding from 1 review
Clinical remission · patients with induction of remission in ulcerative colitis
Trichuris suis eggs showed no clear difference in clinical remission compared with placebo (low certainty).
1 finding from 1 review
Clinical improvement at 12 weeks · patients with induction of remission in ulcerative colitis
Trichuris suis eggs showed no clear difference in clinical improvement at 12 weeks compared with placebo (low certainty).
1 finding from 1 review